| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |